
Genomtec Investor Relations Material
Latest events

Investor Update
Genomtec

Q1 2025
29 May, 2025

Q4 2024
29 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Genomtec S.A
Access all reports
Genomtec S.A. is a biotechnology company specializing in molecular diagnostics. The company develops and commercializes portable and laboratory-based diagnostic solutions using isothermal nucleic acid amplification technology. Its products are designed for rapid and precise detection of infectious diseases, genetic disorders, and other medical conditions. The company is headquartered in Wrocław, Poland, and its shares are listed on the WSE.
Key slides for Genomtec S.A


Investor Update
Genomtec S.A


Investor Update
Genomtec S.A
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
GMT
Country
🇵🇱 Poland